MedPath

US-guided Trocar Versus Seldiger Technique for Percutaneous Cholecystostomy

Not Applicable
Completed
Conditions
Cholecystitis
Interventions
Procedure: Seldinger percutaneous cholecystostomy
Procedure: Trocar percutaneous cholecystostomy
Registration Number
NCT04602156
Lead Sponsor
Attikon Hospital
Brief Summary

A single-center randomized comparison of bedside ultrasound (US)-guided trocar technique versus the US-guided Seldinger technique for percutaneous cholecystostomy

Detailed Description

This is a single-center, randomized, controlled trial (RCT), comparing bedside US-guided trocar technique versus the US-guided Seldinger technique for percutaneous cholecystostomy (PC). The study will randomize a total of 100 consecutive patients (50 in each group) undergoing PC at one large tertiary university hospital. The primary endpoints will be technical success and procedure-related complication rates. Secondary endpoints will be procedural duration, pain assessment, and clinical success after up to 3 months of follow-up.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • All patients requiring PC, regardless of the underlying cause.
  • Signed informed consent form
Exclusion Criteria
  • Age <18 years or >100 years
  • The necessity for CT-guided PC catheter placement, according to the judgment of the performing physician
  • Severe uncontrollable coagulopathy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group SSeldinger percutaneous cholecystostomyPatients will be randomized to undergo PC catheter placement (8-French) using the Sellinger method under US guidance while receiving local anesthesia and opioid analgesic, in a bedside setting, either in the US room or in the ICU.
Group TTrocar percutaneous cholecystostomyPatients will be randomized to undergo PC catheter placement (8-French) using the trocar method under US guidance while receiving local anesthesia and opioid analgesic, in a bedside setting, either in the US room or in the ICU.
Primary Outcome Measures
NameTimeMethod
Technical successAt the end of the procedure

Image verified catheter placement within the gallbladder and subsequent bile aspiration

Procedure-related complications3 months

Minor or major complications attributed to the procedure

Secondary Outcome Measures
NameTimeMethod
Clinical success72 hours

Gradual subsidence of signs, symptoms, and elevated inflammatory markers

Duration of the procedureIntraprocedural

The time period between administration of local anesthesia and pigtail catheter positioning within the gallbladder

Intraprocedural painEnd of the procedure

pain experienced during the procedure assessed using a standard visual analogue score the procedure, as assessed using a standard visual analog score

Post-procedural pain12 hours

Pain experienced up to12 hours after procedure assessed using a standard visual analogue score (VAS - Visual Analog Scale 0-10, 0 representing no pain \& 10 representing worst pain experienced)

Trial Locations

Locations (1)

"Attikon" University General Hospital

🇬🇷

Athens, Attiki, Greece

© Copyright 2025. All Rights Reserved by MedPath